MARKET

GENE

GENE

Genetic
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.190
-0.200
-5.90%
After Hours: 3.250 +0.06 +1.88% 17:14 09/20 EDT
OPEN
3.280
PREV CLOSE
3.390
HIGH
3.340
LOW
3.190
VOLUME
159.75K
TURNOVER
--
52 WEEK HIGH
8.18
52 WEEK LOW
2.770
MARKET CAP
47.94M
P/E (TTM)
-8.8932
1D
5D
1M
3M
1Y
5Y
Genetic Technologies Issues Report IN 6-K Filing
-SEC Filing
SEC Filing · 09/13 17:39
BelHealth Completes Asset Sale of General Genetics Corp.
September 9, 2021–BelHealth Investment Partners, LLC ("BelHealth") is pleased to announce that it has completed the sale of assets of the international division of General Genetics Corporation (GGC), a provider of relationship and clinical genetic testing ...
PR Newswire · 09/09 13:00
Genetic Technologies Reports FY21 Results as it Turns the Corner on its Commercialization Strategy
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, "Company", "GTG"), a global leader in Genomics based tests in health, wellness and serious disease, is pleased to provide the financial results for the year ended June 30, 2021.
GlobeNewswire · 08/31 13:00
Monday's Marijuana Stock Movers
GAINERS: Rhinomed (OTC:RHNMF) shares closed up 10.77% at $0.29 with an estimated market cap of $73.9M.
Benzinga · 08/30 22:58
Cannabis Stocks: Today's Gainers and Losers
GAINERS: Item 9 Labs (OTC:INLB) shares closed up 13.64% at $2.5 with an estimated market cap of $230,523,802.
Benzinga · 08/30 22:52
Arena Pharma, GrowGen & HEXO Among Top Cannabis Stock Movers On August 23, 2021
GAINERS: iAnthus Capital Hldgs (OTC:ITHUF) shares closed up 35.27% at $0.28 with an estimated market cap of $48,870,997.
Benzinga · 08/24 00:02
Genetic Technologies Enters Multi-Billion-Dollar Consumer Genomics Market
EasyDNA Acquisition Accelerates Global Expansion PlansMELBOURNE, Australia, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in Genomics based tests in health, wellness and serious ...
GlobeNewswire · 08/16 12:00
Sundial Growers, MedMen, World Acceptance Among Top Cannabis Stock Movers On July 26, 2021
GAINERS: Khiron Life Sciences (OTC: KHRNF) shares closed up 10.23% at $0.25
Benzinga · 07/26 20:58
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of GENE. Analyze the recent business situations of Genetic through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
EPS
Institutional Holdings
Institutions: 23
Institutional Holdings: 368.47K
% Owned: 2.45%
Shares Outstanding: 15.03M
TypeInstitutionsShares
Increased
4
93.20K
New
3
31.02K
Decreased
6
144.48K
Sold Out
4
34.74K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
-2.11%
Healthcare Providers & Services
-1.72%
Key Executives
Chairman/Director
Peter Rubenstein
Chief Executive Officer
Simon Morriss
Chief Financial Officer/Secretary
Michael Tonroe
Corporate Executive
Mark Ostrowski
Chief Operating Officer
Stan Sack
Executive Director
Jerzy Muchnicki
Other
Richard Allman
Other
M. Luisa Ashdown
Other
Susan Gross
Other
Diana Newport
Non-Executive Director
Nick Burrows
Non-Executive Independent Director
Lindsay Wakefield
No Data
About GENE
Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company focuses on the development and commercialization of genetic risk assessment technology for contracting cancer and other chronic diseases. The Company operates through two geographic segments: Australia and United states of America (USA). Australia segment is the home country of the parent entity and the location of the Company's genetic testing and licensing operations. USA segment is the home of Phenogen Sciences Inc. and GeneType Corporation. The Company’s products include GeneType for Breast Cancer is a test that can determine a woman's risk of developing sporadic breast cancer over a period of time; GeneType for Colorectal Cancer is a test that can determine a patient's risk of developing colorectal cancer over a period of time. The Company focuses on development its Germline testing division for hereditary testing.

Webull offers kinds of Genetic Technologies Limited (ADR) stock information, including NASDAQ:GENE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GENE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GENE stock methods without spending real money on the virtual paper trading platform.